Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patients.

Jain MK, Adams-Huet B, Terekhova D, Kushner LE, Bedimo R, Li X, Holodniy M.

J Viral Hepat. 2015 Jan;22(1):25-36. doi: 10.1111/jvh.12226. Epub 2014 Feb 9.

2.

BB0844, an RpoS-regulated protein, is dispensable for Borrelia burgdorferi infectivity and maintenance in the mouse-tick infectious cycle.

Banik S, Terekhova D, Iyer R, Pappas CJ, Caimano MJ, Radolf JD, Schwartz I.

Infect Immun. 2011 Mar;79(3):1208-17. doi: 10.1128/IAI.01156-10. Epub 2010 Dec 20.

3.

Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions.

Rogers EA, Terekhova D, Zhang HM, Hovis KM, Schwartz I, Marconi RT.

Mol Microbiol. 2009 Mar;71(6):1551-73. doi: 10.1111/j.1365-2958.2009.06621.x. Epub 2009 Jan 23.

4.

MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi.

Margos G, Gatewood AG, Aanensen DM, Hanincov√° K, Terekhova D, Vollmer SA, Cornet M, Piesman J, Donaghy M, Bormane A, Hurn MA, Feil EJ, Fish D, Casjens S, Wormser GP, Schwartz I, Kurtenbach K.

Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8730-5. doi: 10.1073/pnas.0800323105. Epub 2008 Jun 23.

6.

Erythromycin resistance in Borrelia burgdorferi.

Terekhova D, Sartakova ML, Wormser GP, Schwartz I, Cabello FC.

Antimicrob Agents Chemother. 2002 Nov;46(11):3637-40.

Supplemental Content

Loading ...
Support Center